Redbiotec is pleased to announce the appointment of Prof. Mark Tangney, PhD, MBA, Principal Investigator Cork Cancer Research Centre, Irland, as additional exclusive advisor to Redbiotec. Mark is Vice-President of the Irish Society for Gene and Cell Therapy (ISGCT). As a renowned expert in the development of microbes as therapeutics he is a very valuable collaboration partner for Redbiotec’s current and future work in oncology. In particular, Redbiotec will profit a lot from Mark Tangney’s work on the associations between bacteria and cancer.
